Pascal E. R. Girin - 25 May 2023 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Director
Issuer ticker: CLPT
Reported as of: 25 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2023, 14:11:56 UTC
Prior SEC filing: 04 Apr 2023
Next SEC filing: 05 Jul 2023
Source filing: View source filing
Reporting owner signature: Richard F. Mattern, by Power of Attorney for Pascal E.R. Girin

Key filing fact

Pascal E. R. Girin filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 26 May 2023.

Key facts

This page summarizes Pascal E. R. Girin's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 May 2023, 14:11.

Change

Previous filing in this sequence was filed on 04 Apr 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +17,153
Change %
Price: $0.000000
Shares after: 17,153
Date: 25 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,153
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

Footnote F2

The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.